Want to create an interactive transcript for this episode?
Podcast: Surfing the MASH Tsunami
Episode: S3-E27.6 - 5th Global NASH Congress Wrap-Up: Dual Weight Loss Agonists, Expanded Imaging and the Implications for NAFLD
Description: On May 27 and 28, Surfing the NASH Tsunami covered the 5th Global NASH Congress, which discussed a wide range of NAFLD-related topics. This conversation includes two shorter interviews. In the first, Louise Campbell and Aged Diagnostics CEO Rachel Zayas interview Altimmune Chief Medical Officer Scott Harris about dual agonist weight loss agents. In the second, Rachel interviews Antaros Medical Vice President of Global Business Development Caleb Roberts about the increasing value of imaging in the study of Fatty Liver Disease.In the first interview, Scott Harris discusses the value of dual receptor agonists in weight loss. He focuses...